Literature DB >> 28185716

Mitochondrial Complex II: At the Crossroads.

Ayenachew Bezawork-Geleta1, Jakub Rohlena2, Lanfeng Dong3, Karel Pacak4, Jiri Neuzil5.   

Abstract

Mitochondrial complex II (CII), also called succinate dehydrogenase (SDH), is a central purveyor of the reprogramming of metabolic and respiratory adaptation in response to various intrinsic and extrinsic stimuli and abnormalities. In this review we discuss recent findings regarding SDH biogenesis, which requires four known assembly factors, and modulation of its enzymatic activity by acetylation, succinylation, phosphorylation, and proteolysis. We further focus on the emerging role of both genetic and epigenetic aberrations leading to SDH dysfunction associated with various clinical manifestations. This review also covers the recent discovery of the role of SDH in inflammation-linked pathologies. Conceivably, SDH is a potential target for several hard-to-treat conditions, including cancer, that remains to be fully exploited.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28185716      PMCID: PMC7441821          DOI: 10.1016/j.tibs.2017.01.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  117 in total

Review 1.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

2.  SDHAF4 promotes mitochondrial succinate dehydrogenase activity and prevents neurodegeneration.

Authors:  Jonathan G Van Vranken; Daniel K Bricker; Noah Dephoure; Steven P Gygi; James E Cox; Carl S Thummel; Jared Rutter
Journal:  Cell Metab       Date:  2014-06-19       Impact factor: 27.287

Review 3.  Anticancer drugs targeting the mitochondrial electron transport chain.

Authors:  Jakub Rohlena; Lan-Feng Dong; Stephen J Ralph; Jiri Neuzil
Journal:  Antioxid Redox Signal       Date:  2011-09-01       Impact factor: 8.401

4.  Escherichia coli succinate dehydrogenase variant lacking the heme b.

Authors:  Quang M Tran; Richard A Rothery; Elena Maklashina; Gary Cecchini; Joel H Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

5.  Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.

Authors:  Nicolasine D Niemeijer; Thomas G Papathomas; Esther Korpershoek; Ronald R de Krijger; Lindsey Oudijk; Hans Morreau; Jean-Pierre Bayley; Frederik J Hes; Jeroen C Jansen; Winand N M Dinjens; Eleonora P M Corssmit
Journal:  J Clin Endocrinol Metab       Date:  2015-08-10       Impact factor: 5.958

6.  The Saccharomyces cerevisiae succinate dehydrogenase does not require heme for ubiquinone reduction.

Authors:  Kayode S Oyedotun; Clarissa S Sit; Bernard D Lemire
Journal:  Biochim Biophys Acta       Date:  2007-09-29

7.  Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.

Authors:  Rodrigo A Toledo; Yuejuan Qin; Zi-Ming Cheng; Qing Gao; Shintaro Iwata; Gustavo M Silva; Manju L Prasad; I Tolgay Ocal; Sarika Rao; Neil Aronin; Marta Barontini; Jan Bruder; Robert L Reddick; Yidong Chen; Ricardo C T Aguiar; Patricia L M Dahia
Journal:  Clin Cancer Res       Date:  2015-12-23       Impact factor: 12.531

8.  Lysine glutarylation is a protein posttranslational modification regulated by SIRT5.

Authors:  Minjia Tan; Chao Peng; Kristin A Anderson; Peter Chhoy; Zhongyu Xie; Lunzhi Dai; Jeongsoon Park; Yue Chen; He Huang; Yi Zhang; Jennifer Ro; Gregory R Wagner; Michelle F Green; Andreas S Madsen; Jessica Schmiesing; Brett S Peterson; Guofeng Xu; Olga R Ilkayeva; Michael J Muehlbauer; Thomas Braulke; Chris Mühlhausen; Donald S Backos; Christian A Olsen; Peter J McGuire; Scott D Pletcher; David B Lombard; Matthew D Hirschey; Yingming Zhao
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

9.  Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis.

Authors:  Simone Cardaci; Liang Zheng; Gillian MacKay; Niels J F van den Broek; Elaine D MacKenzie; Colin Nixon; David Stevenson; Sergey Tumanov; Vinay Bulusu; Jurre J Kamphorst; Alexei Vazquez; Stewart Fleming; Francesca Schiavi; Gabriela Kalna; Karen Blyth; Douglas Strathdee; Eyal Gottlieb
Journal:  Nat Cell Biol       Date:  2015-08-24       Impact factor: 28.824

10.  Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine.

Authors:  Lili Guo; Alexander A Shestov; Andrew J Worth; Kavindra Nath; David S Nelson; Dennis B Leeper; Jerry D Glickson; Ian A Blair
Journal:  J Biol Chem       Date:  2015-10-31       Impact factor: 5.157

View more
  66 in total

1.  Oxidative modifications of mitochondrial complex II are associated with insulin resistance of visceral fat in obesity.

Authors:  Doan T M Ngo; Aaron L Sverdlov; Shakun Karki; Donia Macartney-Coxson; Richard S Stubbs; Melissa G Farb; Brian Carmine; Donald T Hess; Wilson S Colucci; Noyan Gokce
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-21       Impact factor: 4.310

2.  2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.

Authors:  Magdalena Gorska-Ponikowska; Alicja Kuban-Jankowska; Stephan A Eisler; Ugo Perricone; Giosuè Lo Bosco; Giampaolo Barone; Stephan Nussberger
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

3.  Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx )-related pheochromocytoma and paraganglioma in the pediatric population.

Authors:  Abhishek Jha; Alexander Ling; Corina Millo; Garima Gupta; Bruna Viana; Frank I Lin; Peter Herscovitch; Karen T Adams; David Taïeb; Adam R Metwalli; W Marston Linehan; Alessandra Brofferio; Constantine A Stratakis; Electron Kebebew; Maya Lodish; Ali Cahid Civelek; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-04       Impact factor: 9.236

4.  Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance.

Authors:  Amber E Bannon; Jason Kent; Isaac Forquer; Ajia Town; Lillian R Klug; Kelly McCann; Carol Beadling; Oliver Harismendy; Jason K Sicklick; Christopher Corless; Ujwal Shinde; Michael C Heinrich
Journal:  Clin Cancer Res       Date:  2017-07-19       Impact factor: 12.531

5.  Complex I and II are required for normal mitochondrial Ca2+ homeostasis.

Authors:  Fabian Jaña; Galdo Bustos; José Rivas; Pablo Cruz; Felix Urra; Carla Basualto-Alarcón; Eduardo Sagredo; Melany Ríos; Alenka Lovy; Zhiwei Dong; Oscar Cerda; Muniswamy Madesh; César Cárdenas
Journal:  Mitochondrion       Date:  2019-07-13       Impact factor: 4.160

6.  Permeabilised skeletal muscle reveals mitochondrial deficiency in malignant hyperthermia-susceptible individuals.

Authors:  Leon Chang; Catherine Daly; Dorota M Miller; Paul D Allen; John P Boyle; Philip M Hopkins; Marie-Anne Shaw
Journal:  Br J Anaesth       Date:  2019-03-20       Impact factor: 9.166

Review 7.  New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.

Authors:  David Taïeb; Karel Pacak
Journal:  Trends Endocrinol Metab       Date:  2017-08-31       Impact factor: 12.015

Review 8.  Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology.

Authors:  Salvatore Nesci; Fabiana Trombetti; Alessandra Pagliarani; Vittoria Ventrella; Cristina Algieri; Gaia Tioli; Giorgio Lenaz
Journal:  Life (Basel)       Date:  2021-03-15

9.  Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid.

Authors:  Yang Liu; Ying Pang; Chunzhang Yang; Karel Pacak; Boqun Zhu; Ondrej Uher; Veronika Caisova; Thanh-Truc Huynh; David Taieb; Katerina Hadrava Vanova; Hans Kumar Ghayee; Jiri Neuzil; Mark Levine
Journal:  Clin Cancer Res       Date:  2020-03-09       Impact factor: 12.531

10.  The unassembled flavoprotein subunits of human and bacterial complex II have impaired catalytic activity and generate only minor amounts of ROS.

Authors:  Elena Maklashina; Sany Rajagukguk; T M Iverson; Gary Cecchini
Journal:  J Biol Chem       Date:  2018-04-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.